Korro Bio, Inc. (KRRO) stock
KRRONasdaqPharmaceutical PreparationsFiscal year ends December 31
$14.31−0.10 (-0.69%)
Close on Nov 12, 2026Market cap $210.72MP/E –Yield –
Korro Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Korro Bio's enterprise value was $96.87M on Nov 11, 2026, against -$38.91M a year earlier. Over the last 5 years it ranged from -$112.57M to $555.34M, with a median of $25.50M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $96.87M | – |
| 2025 | Dec 31, 2025 | -$17.20M | -107.9% |
| 2024 | Dec 31, 2024 | $217.75M | – |
| 2023 | Dec 29, 2023 | -$28.11M | – |
| 2022 | Dec 30, 2022 | -$38.80M | – |
| 2021 | Dec 31, 2021 | -$79.90M | -134.3% |
| 2020 | Dec 31, 2020 | $233.23M | – |
| 2019 | Dec 31, 2019 | -$149.04M | – |
See a number that looks wrong?